Product Images Cisatracurium Besylate

This text appears to be a collection of percentage values and the letters "HR". It is difficult to determine the context or purpose of these percentages without further information.*

This is a medication called Cisatracurium besylate Injection that comes in a 5mL single-dose vial. It is usually stored in a temperature range of 2°C to 8°C and should be protected from light. The medication must be used within 21 days of removal from refrigeration in case it is re-refrigerated. The usual dosage and other important information are provided in the package insert. It is made in India and distributed by Zydus Pharmaceuticals in the US. Cisatracurium besylate is a paralyzing agent that can cause respiratory arrest, so facilities for artificial respiration must be available immediately. Each mL of the solution contains 2mg of cisatracurium.*

This is a warning label for the drug Cisatracurium Besylate, which is a paralyzing agent that is stored refrigerated at 2-8°C to maintain its efficacy. The drug comes in a sterile, intravenous form and should be used within 21 days of refrigeration. If administered incorrectly, it can cause respiratory arrest, so facilities for artificial respiration must be immediately available. The dosage should be determined by a medical professional and is not provided on the label.*

Cisatracurium Besylate Injection, USP is a medication available in single-dose vials of 10x 5mL and 1x 105mL. The text is partially distorted and incomplete.*

Cisatracurium Besylate Injection, USP is a medication that comes in a 200 mg/20 mL bottle, with a concentration of 10 mg/mL. Further information is not available due to the lack of readable text.*